Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kramar

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Revue D'Epidemiologie Et De Sante Publique|January 1, 1984
[Comparison of a cohort mortality with the mortality of a reference population. Principle, necessary number of expected deaths and the given power of the test]C Hill, A Rezvani, A Kramar
Gynecologic Oncology|May 1, 1986
Uterine sarcomas: prognostic factors and treatment modalities--study on 209 patientsM George, M H Pejovic, A Kramar
Statistics in Medicine|December 30, 1995
Non-parametric methods for analysing recurrent complications of varying severityR Lancar, A Kramar, C Haie-Meder
Seminars in Oncology|April 1, 1992
Prognostic factors in metastatic diseaseJ P Droz, A Kramar, A Rey
Statistics in Medicine|October 1, 1987
A method of analysis taking into account competing events: application to the study of digestive complications following irradiation for cervical cancerA Kramar, M H Pejovic, D Chassagne
Statistics in Medicine|November 27, 2004
Two-part statistics with paired dataC Bascoul-Mollevi, S Gourgou-Bourgade, A Kramar
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-alphaS D Fosså, A Kramar, J P Droz
Oncology Reports|July 31, 1998
Value of serial carcinoembryonic antigen levels in evaluating the response to chemotherapy in patients with advanced digestive cancersM Ychou, J Duffour, A Kramar, et al.
American Journal of Clinical Oncology|October 1, 1987
Aminothiadiazole (NSC #4728) in patients with advanced colon cancer. A phase II study of the Eastern Cooperative Oncology GroupR F Asbury, A Kramar, D G Haller
Computer Methods and Programs in Biomedicine|September 12, 2001
mROC: a computer program for combining tumour markers in predicting disease statesA Kramar, D Faraggi, A Fortuné, et al.
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Revue D'Epidemiologie Et De Sante Publique|January 1, 1984
[Comparison of a cohort mortality with the mortality of a reference population. Principle, necessary number of expected deaths and the given power of the test]C Hill, A Rezvani, A Kramar
Gynecologic Oncology|May 1, 1986
Uterine sarcomas: prognostic factors and treatment modalities--study on 209 patientsM George, M H Pejovic, A Kramar
Statistics in Medicine|December 30, 1995
Non-parametric methods for analysing recurrent complications of varying severityR Lancar, A Kramar, C Haie-Meder
Seminars in Oncology|April 1, 1992
Prognostic factors in metastatic diseaseJ P Droz, A Kramar, A Rey
Statistics in Medicine|October 1, 1987
A method of analysis taking into account competing events: application to the study of digestive complications following irradiation for cervical cancerA Kramar, M H Pejovic, D Chassagne
Statistics in Medicine|November 27, 2004
Two-part statistics with paired dataC Bascoul-Mollevi, S Gourgou-Bourgade, A Kramar
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-alphaS D Fosså, A Kramar, J P Droz
Oncology Reports|July 31, 1998
Value of serial carcinoembryonic antigen levels in evaluating the response to chemotherapy in patients with advanced digestive cancersM Ychou, J Duffour, A Kramar, et al.
American Journal of Clinical Oncology|October 1, 1987
Aminothiadiazole (NSC #4728) in patients with advanced colon cancer. A phase II study of the Eastern Cooperative Oncology GroupR F Asbury, A Kramar, D G Haller
Computer Methods and Programs in Biomedicine|September 12, 2001
mROC: a computer program for combining tumour markers in predicting disease statesA Kramar, D Faraggi, A Fortuné, et al.
Pageof 12